Peptides: what physicians need to know
News, regulation and evidence on peptides in Trinidad and Tobago: what the law, the regulators and the studies say, with every fact linked to its source.
Clinical practice
Who is a specialist in Trinidad and Tobago? New Medical Board rules
A man who advertised cardiothoracic services in Arima was charged under the Medical Board Act in November 2025. Weeks later, the Medical Board of Trinidad and Tobago's tighter specialist register rules took effect, and they exclude aesthetic qualifications and online courses.
Read article →
Regulation
Falsified Wegovy tablets: Trinidad and Tobago's semaglutide alert
Six weeks after the US approved the first oral semaglutide for weight loss, Trinidad and Tobago's Chemistry, Food and Drugs Division warned that falsified Wegovy tablets were circulating. The pill is not authorised in the country. What physicians need to know.
Read article →
Regulation
Registered drugs in Trinidad and Tobago: the new public database
In January 2026 a parliamentary committee learned that Trinidad and Tobago had no public list of its 21,000-plus registered drugs. In March the Ministry of Health launched an online database. What it does, what it does not do, and why it matters for physicians.
Read article →
Market
CDAP drug shortages in Trinidad and Tobago: metformin to losartan
Trinidad and Tobago's free Chronic Disease Assistance Programme ran short of metformin, losartan, amlodipine and rosuvastatin in 2026. The Health Minister blames procurement and the supply chain; pharmacists blame NIPDEC logistics and unpaid distributors.
Read article →
Regulation
Operation Dunwich: unregistered sildenafil products seized in Trinidad
In May 2026 police, the Chemistry, Food and Drugs Division and Customs seized more than 1,300 unregistered male enhancement and pharmaceutical products from supermarkets in south Trinidad. The CFDD warned they may contain sildenafil. What the law says and what the lab data show.
Read article →